Answers are grounded in this paper and cite their sources.
Prostate cancer remains a significant global public health concern, including in Nigeria, where increasing incidence and late- stage presentation have been reported in urban centres such as Port Harcourt. This study compared prostate-specific antigen (PSA) and prostate-specific membrane antigen (PSMA) levels among male smokers and non-smokers in Port Harcourt, Nigeria, to assess their diagnostic relevance and the influence of lifestyle factors. A comparative cross-sectional design was employed, involving 180 male participants aged 40–60 years: 90 smokers and 90 non-smokers recruited through convenience sampling. Data were collected using structured questionnaires covering demographic and lifestyle variables. We collected, processed, and analysed venous blood samples (5 mL) for PSA and PSMA levels using sandwich enzyme-linked immunosorbent assay (ELISA) techniques. Statistical analyses were performed using GraphPad Prism version 8.02. We compared groups using one-way ANOVA and post hoc tests, with statistical significance set at p < 0.05. We also performed receiver operating characteristic (ROC) curve analysis to evaluate diagnostic performance. The results showed that smokers had significantly higher mean PSA (4.48 ± 1.082 ng/mL) and PSMA (4.00 ± 1.628 ng/mL) levels than non- smokers (PSA: 1.98 ± 0.298 ng/mL; PSMA: 1.88 ± 0.145 ng/mL), with p- values of 0.0003 and < 0.0001, respectively. ROC analysis showed that PSMA had superior diagnostic performance (AUC = 0.766) than PSA (AUC = 0.634). Alcohol consumption was also significantly associated with elevated PSA and PSMA levels, whereas exercise had a significant but variable effect. Age influenced biomarker levels in specific groups, while smoking intensity and duration showed weak, non- significant correlations with both markers. In conclusion, smoking was associated with elevated prostate biomarkers, suggesting an increased risk of prostate dysfunction. PSMA showed greater diagnostic capability than PSA, suggesting it may be a more reliable biomarker for early detection. Integrating both biomarkers with lifestyle interventions may strengthen prostate cancer screening and prevention strategies.
No takes yet. Share an insight, caveat, or question.
Josephine et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: